Effect of Rivaroxaban vs Enoxaparin on MACEs and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Rivaroxaban vs Enoxaparin on Major Cardiac Adverse Events and Bleeding Risk in the Acute Phase of Acute Coronary Syndrome: The H-REPLACE Randomized Equivalence and Noninferiority Trial
JAMA Netw Open 2023 Feb 01;6(2)e2255709, S Zhou, Y Xiao, C Zhou, Z Zheng, W Jiang, Q Shen, C Zhu, H Pan, C Liu, G Zeng, L Ge, Y Zhang, Z Ouyang, G Fu, G Pan, F Chen, L Huang, Q LiuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.